Clinical Trial

Study participants are admitted under the protocol of a care and observation plan. This guide help doctors better understand new therapies for osteoporosis.

Odanacatib, the new medication, is considered to be more convenient than the older class of drugs for osteoporosis, known as bisphosphonates.